PGR and neoplasm: Selected patients ranged from 36 to 85 years of age and carried either invasive ductal, lobular or inflammatory carcinoma, with a broad expression range of ER, PR, HER2 and Ki-67 protein levels, as well as tumor grade varying from 1 to 3.